Humana (HUM) CenterWell president buys 810 shares at $185.205

Rhea-AI Filing Summary

Humana Inc. executive Sanjay K. Shetty, President of CenterWell, reported an open-market purchase of Humana common stock. On this transaction date, he bought 810 shares at a price of $185.205 per share, increasing his directly held stake to 11,657 shares.

The filing also shows option holdings under Humana’s 2019 Amended & Restated Stock Incentive Plan, with 3,964 and 6,572 options from grants vesting in annual increments through 2026 and 2027. Footnotes further note 8,818 restricted stock units that each represent the right to receive one Humana common share.

Insider Trade Summary

Net Buyer: 810 shares ($150,016)

Net Buy 3 txns

Insider Shetty Sanjay K

Role President, CenterWell

Bought 810 shs ($150K)

Type	Security	Shares	Price	Value
Purchase	Humana Common	810	$185.205	$150K
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Humana Common — 11,657 shares (Direct); Options — 3,964 shares (Direct)

Footnotes (1)

1. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Shares purchased on open market at reported price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shetty Sanjay K

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KY 40202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CenterWell

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	02/23/2026		P		810	A	$185.205(4)	11,657(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options(1)	$487.1602							(1)	04/01/2030	Humana Common	3,964		3,964	D
Options(2)	$367.21							(2)	02/21/2031	Humana Common	6,572		6,572	D

Explanation of Responses:

1. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26.

2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

3. Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

4. Shares purchased on open market at reported price.

	Sanjay K. Shetty	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Humana (HUM) executive Sanjay K. Shetty report in this Form 4?

He reported buying 810 Humana common shares in an open-market purchase. The transaction increased his directly held stake to 11,657 shares and accompanied disclosures of option grants and restricted stock units under Humana’s 2019 Amended & Restated Stock Incentive Plan.

How many Humana (HUM) shares did Sanjay K. Shetty buy and at what price?

He bought 810 Humana common shares at a price of $185.205 per share. The transaction was classified as an open-market purchase, reflecting a direct acquisition of additional stock rather than an option exercise or equity award settlement.

What is Sanjay K. Shetty’s Humana (HUM) share ownership after this transaction?

After the purchase, he directly owns 11,657 Humana common shares. This total excludes separate holdings of stock options and restricted stock units, which are disclosed as contingent or derivative rights to acquire additional Humana shares over future vesting periods.

What stock options are disclosed for Sanjay K. Shetty in this Humana (HUM) Form 4?

The filing lists 3,964 and 6,572 options granted under Humana’s 2019 Amended & Restated Stock Incentive Plan. These incentive and non-qualified stock options vest in three annual increments from 2024 through 2026 and from 2025 through 2027, respectively.

What restricted stock units (RSUs) does Sanjay K. Shetty hold in Humana (HUM)?

Footnotes state he holds 8,818 restricted stock units, each representing a contingent right to receive one Humana common share. These RSUs are issued under the 2019 Amended & Restated Plan and are exempt under Rule 16b-3(d)(1)&(3), subject to plan-based vesting conditions.

What is Sanjay K. Shetty’s role at Humana (HUM) related to this Form 4 filing?

He serves as President, CenterWell at Humana Inc., making him a reporting officer under SEC rules. His position requires public disclosure of transactions in Humana equity, including open-market stock purchases, option grants, and restricted stock unit holdings reported here.